Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_004360.5(CDH1):c.1613A>T (p.Asp538Val)

CA338255

216589 (ClinVar)

Gene: CDH1
Condition: CDH1-related diffuse gastric and lobular breast cancer
Inheritance Mode: Autosomal dominant inheritance
Link to MONDO
UUID: 7a7009f6-789d-458a-a313-c7508dc251da
Approved on: 2023-08-21
Published on: 2023-08-21

HGVS expressions

NM_004360.5:c.1613A>T
NM_004360.5(CDH1):c.1613A>T (p.Asp538Val)
NC_000016.10:g.68819327A>T
CM000678.2:g.68819327A>T
NC_000016.9:g.68853230A>T
CM000678.1:g.68853230A>T
NC_000016.8:g.67410731A>T
NG_008021.1:g.87036A>T
ENST00000261769.10:c.1613A>T
ENST00000261769.9:c.1613A>T
ENST00000422392.6:c.1430A>T
ENST00000562836.5:n.1684A>T
ENST00000566510.5:c.*279A>T
ENST00000566612.5:c.1566-2674A>T
ENST00000611625.4:c.1676A>T
ENST00000612417.4:c.1613A>T
ENST00000621016.4:c.1613A>T
NM_004360.3:c.1613A>T
NM_001317184.1:c.1430A>T
NM_001317185.1:c.65A>T
NM_001317186.1:c.-254-2674A>T
NM_004360.4:c.1613A>T
NM_001317184.2:c.1430A>T
NM_001317185.2:c.65A>T
NM_001317186.2:c.-254-2674A>T
More

Uncertain Significance

Met criteria codes 2
PS4_Moderate PM2_Supporting
Not Met criteria codes 24
BS3 BS4 BS1 BS2 BP5 BP7 BP4 BP1 BP3 BP2 PS3 PS2 PS1 BA1 PP4 PP3 PP2 PP1 PM6 PM4 PM5 PM3 PM1 PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen CDH1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 3.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
CDH1 VCEP
The c.1613A>T (p.Asp538Val) variant is absent in the gnomAD cohort (PM2_Supporting). This variant has been reported in at least two families meeting HDGC clinical criteria (PS4_Moderate; SCV000254814.3). In summary, this variant meets criteria to be classified as a variant of uncertain significance based on the ACMG/AMP criteria applied as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): PM2_Supporting, PS4_Moderate.
Met criteria codes
PS4_Moderate
This variant has been reported in at least two families meeting HDGC clinical criteria (SCV000254814.3). Internal lab contributor: Gastric cancer dx @ 40s, pathology not specified. No reported FHx of cancer (Not Meet). SCV000254814.3: Proband #1: male with diffuse gastric cancer by 50s. No family history. (Not Meet) Proband #2: male with metastatic gastric cancer at 30s. FHx of gastric cancer. (Meet) Proband #3: female with diffuse gastric cancer at late 30s (Meet).
PM2_Supporting
Absent in all population databases
Not Met criteria codes
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
In silico splicing predictors (SSF, MaxEnt, NNSPLICE, GeneSplicer) predict no splicing effect.
PP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
2 meioses
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PVS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.